These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 32845503)
1. Chondroitin Sulphate Proteoglycans in the Tumour Microenvironment. Mellai M; Casalone C; Corona C; Crociara P; Favole A; Cassoni P; Schiffer D; Boldorini R Adv Exp Med Biol; 2020; 1272():73-92. PubMed ID: 32845503 [TBL] [Abstract][Full Text] [Related]
2. Proteoglycans and their roles in brain cancer. Wade A; Robinson AE; Engler JR; Petritsch C; James CD; Phillips JJ FEBS J; 2013 May; 280(10):2399-417. PubMed ID: 23281850 [TBL] [Abstract][Full Text] [Related]
3. Chondroitin sulfate proteoglycan 4 enhanced melanoma motility and growth requires a cysteine in the core protein transmembrane domain. Yang J; Price MA; Wanshura LEC; He J; Yi M; Welch DR; Li G; Conner S; Sachs J; Turley EA; McCarthy JB Melanoma Res; 2019 Aug; 29(4):365-375. PubMed ID: 31140988 [TBL] [Abstract][Full Text] [Related]
4. Chondroitin sulfate proteoglycans potently inhibit invasion and serve as a central organizer of the brain tumor microenvironment. Silver DJ; Siebzehnrubl FA; Schildts MJ; Yachnis AT; Smith GM; Smith AA; Scheffler B; Reynolds BA; Silver J; Steindler DA J Neurosci; 2013 Sep; 33(39):15603-17. PubMed ID: 24068827 [TBL] [Abstract][Full Text] [Related]
5. Chondroitin sulfate content and decorin expression in glioblastoma are associated with proliferative activity of glioma cells and disease prognosis. Tsidulko AY; Kazanskaya GM; Volkov AM; Suhovskih AV; Kiselev RS; Kobozev VV; Gaytan AS; Krivoshapkin AL; Aidagulova SV; Grigorieva EV Cell Tissue Res; 2020 Jan; 379(1):147-155. PubMed ID: 31773303 [TBL] [Abstract][Full Text] [Related]
6. Furanodienone overcomes temozolomide resistance in glioblastoma through the downregulation of CSPG4-Akt-ERK signalling by inhibiting EGR1-dependent transcription. Chen L; Liu YC; Zheng YY; Xu J; Zhang Y; Liu WL; Li ZY; Huang GD; Li WP Phytother Res; 2019 Jun; 33(6):1736-1747. PubMed ID: 31006910 [TBL] [Abstract][Full Text] [Related]
7. Role of extracellular matrix and microenvironment in regulation of tumor growth and LAR-mediated invasion in glioblastoma. Kim Y; Kang H; Powathil G; Kim H; Trucu D; Lee W; Lawler S; Chaplain M PLoS One; 2018; 13(10):e0204865. PubMed ID: 30286133 [TBL] [Abstract][Full Text] [Related]
8. The Significance of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Human Gliomas. Schiffer D; Mellai M; Boldorini R; Bisogno I; Grifoni S; Corona C; Bertero L; Cassoni P; Casalone C; Annovazzi L Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30213051 [TBL] [Abstract][Full Text] [Related]
9. Chondroitin sulfate modification of CSPG4 regulates the maintenance and differentiation of glioma-initiating cells via integrin-associated signaling. Niibori-Nambu A; Yamasaki Y; Kobayashi D; Angata K; Kuno A; Panawan O; Silsirivanit A; Narimatsu H; Araki N J Biol Chem; 2024 Mar; 300(3):105706. PubMed ID: 38309500 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localization of chondroitin sulphate and dermatan sulphate proteoglycans in tumour tissues. Fukatsu T; Sobue M; Nagasaka T; Ohiwa N; Fukata S; Nakashima N; Takeuchi J Br J Cancer; 1988 Jan; 57(1):74-8. PubMed ID: 3348950 [TBL] [Abstract][Full Text] [Related]
11. Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. Iozzo RV; Sanderson RD J Cell Mol Med; 2011 May; 15(5):1013-31. PubMed ID: 21155971 [TBL] [Abstract][Full Text] [Related]
12. The Role of Glypican-1 in the Tumour Microenvironment. Lund ME; Campbell DH; Walsh BJ Adv Exp Med Biol; 2020; 1245():163-176. PubMed ID: 32266658 [TBL] [Abstract][Full Text] [Related]